Member Info for MIKODX

https://atamis-1928.cloudforce.com/sfc/p/#0O000000rwim/a/4J000000kEfZ/ezvH65EzZFt1w8.efAUeAiPy8Qd8EiEjHyvrpr5DYnE

Still waiting for an answer.
Aren't there any LT holders who know's a bit more what's going on with ORPH?

I always find whenever the SP rises on no news, hold firmly.
This normally means news has been leaked and news is incoming.
When the SP rises on no news it's normally a leg up to a higher SP, and from there it keeps climbing.

Holding Firmly.

Dividend of 1.0p per share will be paid on 9 April 2021 to ordinary shareholders on the register on 12 March 2021.

I wonder if it's going to gap up to the 26th November?

Could happen as fast as it dropped.

The confidence shown by investors in this stock puts my mind at ease. The loading up has been going on for months now. A breakout surely is imminent.

ORPH shares have been heavily diluted which doesn't help. Might get the odd tree shake here and there but this wont seriously start moving forward until ORPH gives an update on how the merger has affected the company whether positive or negatively.

Going by the last update and according to the markets, we have improved turnover and making healthy profits. That will have to be officially announced before we can start moving up. In the meantime I'll just wait, ORPH has been steady for almost 3 months without dropping below 20, and have good fundamentals in place for the next big push North in the new year.

Good signs heading into the new year. Could be above £1 before then.

This will mean more antibody tests will have to be done.

All I'm hearing on the news now is talk of men donating blood over the xmas to be used as blood plasma treatment for Covid.

If they've given approval then surely the ABC-19 gets approved as well? It's being used by the Govt and is currently one of the most accurate LFT's out there.

Antibody tests will take longer to produce and analyse. Those who test negative will be told to continue to follow covid rules, those who test positive will be tested again using the more accurate PCR tests where a higher amount of blood is drawn. The results are then confirmed and the blood is then stored and later used for analysis and possible blood plasma treatment. Fully expect the second order anytime soon, and with it will hopefully come more confidence in our product, and attract future orders both here and abroad.

When you look at how other Hydrogen companies are performing, it is surprising that AFC's SP is so low. It's no wonder it's attracting so many investors.

This is even more interesting.

https://www.sharesmagazine.co.uk/article/dont-get-sucked-into-the-hydrogen-hype

https://bidstats.uk/tenders/?q=abingdon+health&ntype=award

Ok let's do the maths. This RNS relates back to the RNS we got on 10 August 2020. The contract I believe was worth 4M and was to be completed by end of Q1 2021. If it's been renewed to end of Q4 2021 then that's 16M. That is a significant amount, shouldn't that get the SP flying? Or is the 4M priced in for the full year?

I can just feel it. Come on Colin, tell your mate Boris to get his finger out.

Just topped up a substantial amount.

I'm in for the long haul.

Actually I was just looking at ITM and noticed that in 2019 there share price was similar to that of AFC 20p. Today their SP is £4.31. If AFC can get to that level I'd be more than happy.

Glad everyone is feeling confident about this, thanks for the feedback.
I think i'll pump some more in for the long term.